Noncontrolling Interest

3 Months Ended

Jun. 30, 2011

Noncontrolling Interest Disclosure [Text Block]

NOTE 12 – NONCONTROLLING INTEREST

Noncontrolling interest represents the minority stockholders’ proportionate share of 5% of the equity of Nanchong Chunfei, 14.5% of the equity of Chunfei Chemical and 21.34% of equity of Hedi Medicine. The Company's controlling interest requires that Nanchong Chunfei, Chunfei Chemical and Hedi Medicine’s operations be included in the Company’s Consolidated Financial Statements.

Beginning Balance at September 30, 2010 and 2009	$	1,632,834			1,330,983
Proportionate share of Net Income from Chunfei Chemical		(111,735	)		138,426
Proportionate share of Net Loss from Hedi Medicine		(16,403	)		(56,433	)
Proportionate share of Net Income from Nanchong Chunfei		82,944			103,142

Add: Proportionate share of other comprehensive income		-			10,016

Ending balance at June 30, 2011 and 2010	$	1,587,640		$	1,526,134

- Definition

The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.

+ References+ Details